Lourdes Ibañez Toda
Jefe de Grupo Senior
Research group
Lourdes Ibáñez Toda graduated in Medicine from the Autonomous University of Barcelona in 1977 and obtained her Doctor of Medicine degree from the same university in 1981.
Between 1993 and 1994, she completed a stay at the Massachusetts General Hospital in Boston, where she studied the mechanisms involved in the pathophysiology of polycystic ovary syndrome. Subsequently, she has developed international collaborations with various European (Belgium, Germany, United Kingdom) and US-based research groups working on the subject, resulting in numerous publications in high-impact factor journals (H-index 63) and invited presentations, as well as a consensus text on the pathophysiology, diagnosis, and treatment of polycystic ovary syndrome in adolescents (2017, revised 2023).
Her trajectory has been recognized with the Research Award (2013), granted by the European Society for Paediatric Endocrinology (ESPE), the National Research Award (2014), granted by the Fundació Catalana per a la Recerca i Innovació(Government of Catalonia), the Visionary Award from the Human Growth Foundation (USA, 2022), and the International Excellence in Endocrinology Award (American Endocrine Society, USA, 2022). Lourdes Ibáñez is also the coordinator of the Paediatric & Adolescent Working Group of the ESPE, of the study group Pequeño para la Edad Gestacional of the Sociedad Española de Endocrinología Pediátrica, and the group leader of CIBERDEM (Carlos III Health Institute, Madrid).
Since 2020, she has been a Professor of Paediatrics at the University of Barcelona (UB); since 2012, she has been the director of the Master's Degree in Paediatric Endocrinology and Diabetes at the University of Barcelona (UB), and since 2016, the head of clinical research in the endocrinology service. Currently, she coordinates the research area at the IRSJD on "Adaptive Response, Metabolism, and Immunobiology".
Professional network profiles
Related websites
SJD Barcelona Children's Hospital Last Publications
- de Zegher, F and Ibañez-Toda L Combined contraceptive pills for androgen excess, not for polycystic ovary syndrome in adolescent girls. ACTA PAEDIATRICA . 113(7): 1481-1482.
- García-Beltran C, Peyrou M, Navarro-Gascon A, López-Bermejo A, de Zegher F, Villarroya F and Ibañez-Toda L Organokines and liver enzymes in adolescent girls with polycystic ovary syndrome during randomized treatments Frontiers in Endocrinology . 15: 1325230-1325230.
- de Zegher F, Díaz-Silva M and Ibañez-Toda L Adolescent polycystic ovary syndrome without obesity: HOTAIR rs1443512 genotype relates to fat mass and to the redistribution of fat mass on low-dose pioglitazone JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION . 47(4): 1037-1043.
Projects
- Project name:
- Variaciones longitudinales del perfil de expresión de microRNAs exosomales en niños con bajo peso para la edad gestacional con y sin recuperación de peso y talla postnatal
- Leader
- Paula Casano Sancho, Marta Díaz Silva
- Funding entities:
- Casano Sancho, Paula, Instituto de Salud Carlos III (ISCIII), Fundació Privada per a la Recerca i la Docència Sant Joan de Déu - FSJD
- Code
- PI22/01424
- Starting - finishing date:
- 2023 - 2025
- Project name:
- Efectos del tratamiento con spiomet a mitad de dosis en niñas con pubertad adelantada y aceleración de la maduración ósea: estudio multicéntrico, aleatorizado y controlado con placebo
- Leader
- Lourdes Ibañez Toda
- Funding entities:
- Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
- Code
- ICI21/00005
- Starting - finishing date:
- 2022 - 2025
- Project name:
- SGR 2022-2024_Resposta adaptativa, metabolisme e immunobiologia. Endocrinologia metabòlica
- Leader
- Lourdes Ibañez Toda
- Funding entities:
- Agaur - Agència de Gestió d'Ajuts Universitaris i de Recerca
- Code
- 2021 SGR 00659
- Starting - finishing date:
- 2022 - 2025
News
-
Research into treatments to combat obesity and excessive sleepiness in children with Prader-Willi syndrome
Researchers from Sant Joan de Déu have promoted various research projects in recent years to advance the understanding of Prader-Willi syndrome and study new treatments for children affected by this rare disease.
-
Brown adipose tissue activity is higher in girls during the first year of life
A team led by Dr Lourdes Ibáñez and Dr Francesc Villarroya, IRSJD researchers, publishes the first study that shows the very early appearance of differences in the activity of the brown adipose tissue between girls and boys.
-
Dr. Lourdes Ibañez coordinates the European SPIOMET4HEALTH project: a new treatment for polycystic ovary syndrome in adolescents and young women
Dr. Lourdes Ibañez, from the Institut de Recerca Sant Joan de Déu, coordinates the new European SPIOMET4HEALTH will test the efficacy of this new treatment for Polycystic Ovary Syndrome (PCOS) in adolescent girls and young adult women, in a multi-centric phase II clinical trial.